MedTrace Logo

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

NCT06441786 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-09-29

No results posted yet for this study

Summary

The goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis.

The main questions it aims to answer are:

1. How does the recruitment to the study work and what is the retention rate?
2. What is the level of participant compliance?
3. Is the treatment adherence satisfactory, are there any practical problems with treatment delivery?
4. Are the outcome measures and assessment procedures feasible?
5. Do the participants accept the treatment, are there any reports of adverse effects?
6. What are the preliminary effects of the treatment regarding

1. Symptoms of anxiety and/or depression
2. Quality of life
3. Functional impairment
4. Subjective level of stress
5. Central metacognitive processes
7. Are changes in metacognitive processes related to changes in anxiety and depression?

The participants will partake in metacognitive group treatment of 10 sessions following an initial screening.

Conditions

  • Anxiety Depression

Interventions

BEHAVIORAL

A metacognitive group therapy of depression and anxiety in youth with autism

The treatment model is based on Adrian Wells' transdiagnostic A-M-C model and treatment structure described in Wells (2009) "Metacognitive therapy for anxiety and depression". The group treatment is delivered in 10 weekly sessions.

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Timo Hursti, Ph.D. · Uppsala University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-12
Primary Completion
2026-08-29
Completion
2026-08-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06441786 on ClinicalTrials.gov